Biotangents
PrivateLast Round
Series A
Nov 28, 2024
Total Funding Raised
$9.22M
Company Overview
Biotangents operates in Healthcare & Life Sciences and is based in Penicuik. Its latest recorded funding round was a Series A round in November 2024.
Biotangents is a biotechnology company that develops veterinary diagnostic devices designed to detect infectious diseases in livestock.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biotangents Comparables
Compare Biotangents with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Micron Agritech | 80% | |
| Vimian Group | 69% | |
| Virbac | 66% |
For institutional investors. Book with your work email.
Biotangents Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 28, 2024 | ||||
| Debt | May 18, 2022 | ||||
| Early Funding | May 18, 2022 | ||||
| Early Funding | Aug 1, 2021 | ||||
| Early Funding | May 6, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Biotangents Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Debt |
| Eos Advisory | Series A |
| Scottish Investment Bank (Scottish Enterprise) | Early Funding, Grant, Seed, Series A |
| Kelvin Capital | Grant, Seed, Series A, Early Funding |
| British Business Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Monthly visitors grew 37% MoM, reaching 903.
- Jul 6, 2025
Monthly visitors increased 32% MoM.
For institutional investors. Book with your work email.
Biotangents Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Biotangents's valuation, stock price, and market status.
Is Biotangents a public or private company?
Biotangents is a private company.
What is the current stock price of Biotangents?
Biotangents is a private company, so its shares have no public market price. Caplight tracks Biotangents's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biotangents worth (valuation)?
Valuation information for Biotangents is not publicly available.
Can I buy Biotangents stock?
Biotangents shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biotangents's last funding round?
Biotangents's most recent funding round was Series A on November 28, 2024.
Who are the main investors in Biotangents?
Key investors in Biotangents include Eos Advisory, Kelvin Capital, British Business Investments.
Will Biotangents IPO soon?
No public IPO plans have been announced for Biotangents.
How can I track Biotangents secondary market activity?
Caplight tracks bids, offers, and trades in Biotangents's shares on secondary markets.